Article Text
Statistics from Altmetric.com
Botulinum toxin type A (BoNT-A) is used to treat dystonia. The commonest form, cervical dystonia, is more common in women; since many are still of childbearing age,1 some women on botulinum toxin treatment inevitably will either be planning to become pregnant or may wish to be treated while pregnant. The use of BoNT-A for chronic migraine—a female-predominant disorder—will make botulinum treatment an increasingly common issue for women,2 leaving aside the use of BoNT-A in a cosmetic setting. To inform discussions with patients, clinicians need to understand the known …
Footnotes
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Ralph Gregory, Poole, UK.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- Editors' choice
Read the full text or download the PDF:
Other content recommended for you
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®
- British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
- Factors affecting the health - related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double - blind, placebo - controlled study
- Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature
- Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia
- Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis
- Oropharyngeal swallowing in craniocervical dystonia